ABSCI CORP Comprehensive Income
ABSCI CORP (ABSI) reported Comprehensive Income of -$33.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-11
- ABSCI CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$33.36M.
- ABSCI CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$29.89M.
- ABSCI CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$29.47M.
- ABSCI CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$28.52M.
- ABSCI CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$114.59M.
- ABSCI CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$103.07M.
- ABSCI CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$110.48M.
- ABSCI CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$105.01M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$33.36M 10-Q · filed 2026-08-11 | -$63.25M 10-Q · filed 2026-08-11 | -$92.72M derived: sum of 3 quarters · filed 2026-08-11 | -$121.24M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$29.89M 10-Q · filed 2026-05-07 | -$59.36M derived: sum of 2 quarters · filed 2026-05-07 | -$87.87M derived: sum of 3 quarters · filed 2026-05-07 | -$118.15M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$29.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$57.99M derived: sum of 2 quarters · filed 2026-03-24 | -$88.27M derived: sum of 3 quarters · filed 2026-08-11 | -$114.59M 10-K · filed 2026-03-24 |
| 2025-09-30 | -$28.52M 10-Q · filed 2025-11-12 | -$58.79M derived: sum of 2 quarters · filed 2026-08-11 | -$85.12M 10-Q · filed 2025-11-12 | -$114.36M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$30.28M 10-Q · filed 2026-08-11 | -$56.60M 10-Q · filed 2026-08-11 | -$85.84M derived: sum of 3 quarters · filed 2026-08-11 | -$112.87M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$26.32M 10-Q · filed 2026-05-07 | -$55.56M derived: sum of 2 quarters · filed 2026-05-07 | -$82.59M derived: sum of 3 quarters · filed 2026-05-07 | -$107.33M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$29.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$56.27M derived: sum of 2 quarters · filed 2026-03-24 | -$81.00M derived: sum of 3 quarters · filed 2026-03-24 | -$103.07M 10-K · filed 2026-03-24 |
| 2024-09-30 | -$27.03M 10-Q · filed 2025-11-12 | -$51.77M derived: sum of 2 quarters · filed 2025-11-12 | -$73.83M 10-Q · filed 2025-11-12 | -$97.36M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$24.73M 10-Q · filed 2025-08-12 | -$46.80M 10-Q · filed 2025-08-12 | -$70.33M derived: sum of 3 quarters · filed 2025-08-12 | -$92.23M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$22.07M 10-Q · filed 2025-05-13 | -$45.59M derived: sum of 2 quarters · filed 2025-05-13 | -$67.50M derived: sum of 3 quarters · filed 2025-05-13 | -$109.22M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$23.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$45.43M derived: sum of 2 quarters · filed 2025-03-18 | -$87.15M derived: sum of 3 quarters · filed 2025-03-18 | -$110.48M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$21.91M 10-Q · filed 2024-11-12 | -$63.63M derived: sum of 2 quarters · filed 2024-11-12 | -$86.96M 10-Q · filed 2024-11-12 | -$106.58M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$41.72M 10-Q · filed 2024-08-14 | -$65.05M 10-Q · filed 2024-08-14 | -$84.67M derived: sum of 3 quarters · filed 2024-08-14 | -$111.84M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$23.33M 10-Q · filed 2024-05-14 | -$42.95M derived: sum of 2 quarters · filed 2024-05-14 | -$70.12M derived: sum of 3 quarters · filed 2024-05-14 | -$98.84M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$19.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$46.79M derived: sum of 2 quarters · filed 2024-03-21 | -$75.51M derived: sum of 3 quarters · filed 2024-03-21 | -$105.01M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$27.17M 10-Q · filed 2023-11-14 | -$55.89M derived: sum of 2 quarters · filed 2023-11-14 | -$85.39M 10-Q · filed 2023-11-14 | -$110.56M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$28.72M 10-Q · filed 2023-08-14 | -$58.22M 10-Q · filed 2023-08-14 | -$83.39M derived: sum of 3 quarters · filed 2023-08-14 | -$107.02M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$29.50M 10-Q · filed 2023-05-15 | -$54.67M derived: sum of 2 quarters · filed 2023-05-15 | -$78.31M derived: sum of 3 quarters · filed 2023-05-15 | -$119.52M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$25.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$48.80M derived: sum of 2 quarters · filed 2023-03-30 | -$90.01M derived: sum of 3 quarters · filed 2023-03-30 | -$100.97M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$23.64M 10-Q · filed 2022-11-09 | -$64.85M derived: sum of 2 quarters · filed 2022-11-09 | -$75.81M 10-Q · filed 2022-11-09 | -$80.75M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$41.21M 10-Q · filed 2022-08-11 | -$52.17M 10-Q · filed 2022-08-11 | -$57.11M derived: sum of 3 quarters · filed 2022-08-11 | -$60.86M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$10.96M 10-Q · filed 2022-05-11 | -$15.90M derived: sum of 2 quarters · filed 2022-05-11 | -$19.65M derived: sum of 3 quarters · filed 2022-05-11 | -$22.66M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$8.69M derived: sum of 2 quarters · filed 2022-03-22 | -$11.70M derived: sum of 3 quarters · filed 2022-03-22 | -$14.35M 10-K · filed 2022-03-22 |
| 2020-09-30 | -$3.75M 10-Q · filed 2021-11-09 | -$6.76M derived: sum of 2 quarters · filed 2021-11-09 | -$9.41M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$3.01M 10-Q · filed 2021-09-07 | -$5.67M 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |